Background {#Sec1}
==========

Migraine is one of eight disorders that affect over 10% of the world population \[[@CR1]\]. It is one of the most common chronic pain conditions among the young adult population \[[@CR2]\], with prevalence peaking between 20 and 30 years of age. Women \[[@CR3]\] and students are some of the populations most widely affected by migraine \[[@CR4]\]. With a large prevalence of around 37%, it involves a mean annual cost per person of €1222, with Spain having the highest total cost in Europe \[[@CR3]\]. Since 1990 the number of years lived with disability caused by migraine has increased by 51.2% \[[@CR5]\].

The Migraine Disability Assessment (MIDAS) questionnaire was developed as a tool to determine headache-related disability \[[@CR6]\]. It estimates productive time lost to the disabling effects of headache over the three preceding months.

MIDAS has been transculturally adaptated to numerous languages, and has been widely used for research purposes and in clinical practice to develop treatment strategies based on the patient's level of disability \[[@CR7]\]. To the best of our knowledge, there is no validated Spanish version of the MIDAS questionnaire, and its clinimetric properties in that context remain unknown. However, several studies have used the MIDAS questionnaire in Spanish populations to determine both migraine-related disability \[[@CR8], [@CR9]\] and the difficulty encountered by patients when using the questionnaire \[[@CR10]\].

Given the high prevalence and costs of migraine, particularly in Spain, and the lack of a reliable tool, written in Spanish, to measure migraine-related disability, we have analyzed the clinimetric properties of the Spanish version of the MIDAS questionnaire in university students, one of the populations most commonly affected by migraine.

Material and methods {#Sec2}
====================

Design {#Sec3}
------

This is an observational, cross-sectional study for the validation of a measuring instrument, in which we have analyzed the construct validity, internal consistency, and concurrent validity of the MIDAS questionnaire. For test-retest reliability, a subsample of 29 subjects was evaluated twice with a time interval of 21 days.

Participants {#Sec4}
------------

The participants were young adult undergraduate and graduate students over 18 years. In order to be included, all participants were required to have been diagnosed with migraine. They were then examined by a physician (F.H.) to check if they fulfilled at that time the criteria described in the third edition of *The International Classification of Headache Disorders* \[[@CR11]\].

We followed recommendations to include at least 10 subjects per item and to have at least 100 subjects for the purposes of the internal consistency and factor analysis \[[@CR12]\]. A total of 230 subjects were contacted within the University of Jaén (Spain), of which 202, aged between 18 and 33, participated in this study between the months of March and June 2017. Finally, 153 participants met the inclusion criteria and completed all tasks. The selection process is shown in Fig. [1](#Fig1){ref-type="fig"}. Fig. 1Flow diagram of participants

The present study was approved by the Bioethics Committee of the University of Jaén (Reference number ABR 7/17) and was developed in accordance with the Helsinki Declaration, good clinical practices, and all applicable laws and regulations. All participants provided written informed consent prior to their inclusion in the study.

Measurements {#Sec5}
------------

Prior to completing the questionnaires, the participants reported their sociodemographic data including age, gender, weight, height, smoking habit, and degree of physical activity.

Two bilingual experts performed independent translations of the English version of the MIDAS questionnaire \[[@CR6]\] into Spanish, following the guidelines recommended by the International Quality of Life Assessment project for cross-cultural translation \[[@CR13]\]. Secondly, a consensus for a preliminary forward translation was reached between translators and researchers. Later, two bilingual experts performed a backward translation of the agreed Spanish version into English. The last English translation was compared with the original version of the MIDAS questionnaire in order to verify whether they had achieved semantic, linguistic, conceptual, and technical equivalence. Finally, 15 participants filled the Spanish version of the questionnaire (Additional file [1](#MOESM1){ref-type="media"}) to verify if the instructions, questions, and answering options were understandable.

The MIDAS questionnaire measures the degree of migraine-related disability experienced over the last 3 months. It comprises seven items, the first five of which constitute the main scale and inquire about three distinct dimensions: workplace (two first items); domestic tasks (third and fourth items); and attendance to social, family, or leisure activities (fifth item). The sixth and seventh items refer respectively to the frequency and intensity of headaches over the last 3 months, and provide relevant data for clinicians to make informed decisions. The first six items must be answered with the number of days that headache conditioned any of the activities described in each question over the last 3 months. The seventh item is a Numeric Pain Scale, in which zero indicates absence of pain and ten indicates the maximum pain subjects believe they can withstand. According to the MIDAS-main scale score, which comprises the sum of the answers to items 1 to 5, subjects could be classified in 5 disability grades: Grade I (score 0--5): no disability or low disability; Grade II (score 6--10): mild disability; Grade III (score 10--20): moderate disability; and Grade IV (score \> 21): severe disability.

The 12-Item Short Form Health Survey (SF-12) was used in the present study to measure quality of life \[[@CR14]\]. This is a self-administered questionnaire extracted from the SF-36 by means of multiple regression. The SF-12 consists of 12 items from which the physical and mental component summaries (PCS-12 and MCS-12, respectively) yield a single score each. These two summary components showed high levels of internal consistency (Cronbach's alpha value of 0.85 for PCS-12 and 0.78 for MCS-12) \[[@CR14]\].

Statistical analysis {#Sec6}
--------------------

Data management and analysis were performed using the IBM SPSS Statistics package, version 23.0 (SPSS Inc., Chicago, IL) and the MedCalc statistical software, version 16.5.4 (MedCalc Software bv, Ostend, Belgium; <https://www.medcalc.org>; 2019). Data were expressed as means and standard deviations (SD) for continuous variables and as frequencies and percentages for categorical variables. The Kolmogorov-Smirnov test was used to test the normality of continuous variables. The level of statistical significance was set at *P* \<  0.05.

A Principal Component Analysis (PCA) with varimax rotation was performed to measure the validity of the MIDAS construct. To test the feasibility of the factorial analysis we used Barlett's sphericity test. The suitability of the sample was analyzed using the Kaiser-Meyer-Olkin (KMO) test.

Internal consistency of the instrument was assessed through item analysis and the calculation of Cronbach's alpha. Values of Cronbach's alpha below 0.70 were considered weak, between 0.70 and 0.90 were considered good, and above 0.90 were interpreted as indicative of item redundancy \[[@CR15]\].

Test-retest reliability was analyzed using the Intraclass Correlation Coeficient (ICC) as described by Shrout & Fleiss. Reliability was considered low for ICC values below 0.40, moderate for values between 0.40 and 0.75, high for ICC values between 0.75 and 0.90, and excellent for values higher than 0.90 \[[@CR16]\].

Spearman's correlation coefficient was used to analyze the tool's concurrent validity with the SF-12 questionnaire. A correlation coefficient greater than 0.5 indicated a strong correlation, whereas values between 0.30 and 0.50 indicated a moderate correlation \[[@CR17]\].

Results {#Sec7}
=======

Out of the 153 subjects who completed the study (average age = 21.76; SD = 3.65), 45 were men and 108 were women. According to the disability level, 41.8% of participants showed little to no disability, 32% showed mild disability, 16.3% showed moderate disability, and 9.8% showed severe disability (Table [1](#Tab1){ref-type="table"}). Table 1Description of the participantsVARIABLESMigraineurs (*n* = 153)CONTINUOUSMeanSDAge21.763.65Height (cm)168.187.95Weight (kg)64.9311.95BMI (kg/m^2^)22.853.17PCS-1252.427.45MCS-1241.9311.49Frequency of headache (Item 6)10.1114.84Pain intensity (Item 7)5.482CATEGORICALF%GenderMale4570.6Female10829.4SmokerYes2113.7No13286.3Physical activityYes6643.1No8756.9Kind of migraineMigraine12078.4Chronic migraine3321.6Attack duration4 h7347.74-24 h6240.5\> 241811.8PhotophobiaYes8454.9No6945.1PhonophobiaYes10468No4932Nausea or VomitingYes9058.8No6341.2Disability grade (MIDAS)No disability6441.8Mild4932Moderate2516.3Severe159.8*BMI* Body Mass Index, *PCS-12* Physical Component Summary of the 12-Item Short Form Health Survey (SF-12), *MCS-12* Mental Component Summary of the SF-12, *MIDAS* Migraine Disability Assessment

The PCA showed a structure composed of two factors. The first factor included items 1, 3, and 5, which are questions that imply refraining from engaging in activities, regardless of type, due to headache. The second factor included items 2 and 4, which imply a decrease of 50% in the performance at work or at domestic tasks (Table [2](#Tab2){ref-type="table"}). The variance explained was 88.35%, Bartlett's sphericity test was statistically significant (X^2^ = 707.97; *p* \<  0.001), and the KMO index was 0.612, indicating that the sample used can be considered adequate for the factor analysis. Table 2Percentages of variance explained by the factor analysis performed using Principal Components AnalysisComponentInitial eigenvaluesExtraction sums of squared loadingsRotation sums of squared loadingsTotal% of variance^a^Cumulative %^b^Total% of variance^a^Cumulative %^b^Total% of variance^a^Cumulative %^b^12.84656.92256.9222.84656.92256.9222.82356.46056.46021.57131.42888.3501.57131.42888.3501.59531.89088.35030.4298.58596.93540.1132.25499.18850.0410.812100.000^a^Percentage of variance that explains each factor of the questionnaire structure^b^Total percentage of variance explained jointly by the factors that compose the questionnaire structure

Internal consistency analysis showed a Cronbach's alpha of 0.797 for the MIDAS-main scale score, which may improve slightly if items 2 and 4 were eliminated (Table [3](#Tab3){ref-type="table"}). In addition, test-retest reliability was high for the MIDAS-main scale score (ICC = 0.81 95% CI: 0.63--0.90 *p* \<  0.001), excellent for item 6 (headache frequency; ICC = 0.90 95%; CI: 0.79--0.95; *p* \<  0.001), and moderate for item 7 (headache intensity; ICC = 0.63; 95% CI: 0.34--0.80; *p* \<  0.001). The analysis showed a strong correlation of the MIDAS-main scale score with headache frequency, and a moderate correlation with both headache intensity and PCS-12. Additionally, moderate correlations were found between PCS-12 scores and the frequency and intensity of headaches (Table [4](#Tab4){ref-type="table"}). Table 3Item reliability analysisAverage scale if the item is deletedVariance of scale if the item is deletedCorrected items - total correlationCronbach's alpha if the item is deleted^a^Item 110.654302.3330.8320.661Item 28.765538.8780.1340.851Item 39.078288.6250.8460.653Item 49.137523.0400.2030.842Item 59.686287.6770.8780.639Item 1--5: questions in the MIDAS questionnaire^a^Cronbach's alpha value if the item is deleted from the analysisTable 4Correlations among MIDAS-main scale score. Frequency and intensity of headache, and physical and mental components summary of the SF-12 questionnaireMIDAS-main scale scoreHeadache frequencyHeadache intensityRho Spermann*P*Rho Spermann*P*Rho Spermann*P*Headache frequency0.529\<  0.001Headache intensity0.343\<  0.0010.459\<  0.001PCS-12−0.326\<  0.001−0.334\<  0.001−0.268\< 0.001MCS-12−0.1530.060−0.0290.721−0.0270.741*MIDAS* Migraine Disability Assessment, *PCS-12* Physical Component Summary of the 12-Item Short Form Health Survey (SF-12), *MCS-12* Mental Component Summary of the SF-12, *MIDAS* Migraine Disability Assessment

Discussion {#Sec8}
==========

The MIDAS questionnaire has been used in Spanish populations to assess migraine-related disability \[[@CR8]--[@CR10]\]. However, to the extent of our knowledge, there is no validated Spanish version of the questionnaire, and this is the first study to analyze the clinimetric properties of the Spanish version of the MIDAS questionnaire. Our results for a population of university students show a factorial structure composed of two factors, good internal consistency data, results ranging from good to excellent in test-retest reliability, and a moderate correlation with PCS-12 in the concurrent validity analysis of the questionnaire. Therefore, our results indicate that the Spanish version of the MIDAS questionnaire is a valid and reliable instrument to measure migraine-related disability.

However, our results showed a different factorial structure to the one proposed by the original authors \[[@CR6]\]. Unlike the original structure, our PCA clearly identified two factors that explained nearly 90% of the variance. The first factor was composed of items that imply refraining from certain activities, such as working, doing house chores, or attending social events, due to migraine (items 1, 3, and 5). The second factor was composed by items that involve a 50% decrease in performance of both work-related and domestic tasks because of migraine (items 2 and 4). This two-factor structure is indicative of the variable influence that migraine has on personal performance and, consequently, on disability.

In our population, nearly two thirds of migrainous women and men presented some kind of disability, and this was related to decreased physical quality of life. These results are in agreement with previous studies \[[@CR18], [@CR19]\]. In addition to its physical effects, several cognitive functions such as processing speed, attention, memory, verbal skills, and executive function, which are all particularly important for the daily performance of our population, are negatively affected by migraine \[[@CR20]\] and their debilitating consequences have a considerable impact on daily-life activities \[[@CR21]\]. In the present study, the first factor of the factorial structure includes all items that reflect total disability for the purposes of engaging in any professional or social activity, while the second factor reflects a partial disability level.

The reliability parameters of the Spanish version of the MIDAS questionnaire were satisfactory as a whole. We have obtained good internal consistency results, comparable to those previous studies \[[@CR18], [@CR19], [@CR22]--[@CR24]\] including the most recent ones \[[@CR25], [@CR26]\]. Results from the test-retest reliability analysis ranged from good to excellent. Our analysis also revealed that the two additional items of the questionnaire are reliable and provide relevant information that may be helpful for clinicians, in agreement with statements made by the original authors of the questionnaire \[[@CR6]\]. The results obtained are in accordance with the procedure for the measurement of migraine-related disability proposed by the original authors, although the factorial structure shown in the present study was different. In fact, it suggests that migraine-related disability may be assessed differently, given the specific effects of migraine on cognitive functions regardless of its severity, thereby generating different disability levels that may lead from absenteeism to presentism \[[@CR4]\].

The results of the present study show good clinimetric properties for the Spanish version of the MIDAS questionnaire, evidencing that this version is a consistent and reliable measure tool.

This study has several limitations. Although the prevalence of migraine is high among student populations, our results are only valid for the sample under analysis and not be extrapolated to other populations. In addition, our results may only be valid for a Spanish population due to structural and organizational differences among the educational systems of different countries.

Future studies should analyze the clinimetric properties of the MIDAS questionnaire for different populations and countries. It would be also advisable to examine the relation between headache and other concomitant disorders such as neck pain or dizziness, as well as to analyze the factors related to the presence of headache in university students and the impact that this disorder may have on this population.

Conclusions {#Sec9}
===========

The Spanish version of the MIDAS questionnaire is a valid and reliable tool for measuring migraine-related disability in young university students. Moreover, the two additional items of the questionnaire provide information that can help clinicians discriminate between subjects with and without headache, and enable a wider application of this scale.

Supplementary information
=========================

 {#Sec10}

**Additional file 1.** Spanish version of the Migraine Disability Assessment (MIDAS) questionnaire.
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